135 related articles for article (PubMed ID: 37886818)
1. Mitochondrial subtype
Li Q; Jia Y; Tang B; Yang H; Yang Q; Luo X; Pan Y
Biomarkers; 2023 Dec; 28(7):643-651. PubMed ID: 37886818
[TBL] [Abstract][Full Text] [Related]
2. Dissecting super-enhancer driven transcriptional dependencies reveals novel therapeutic strategies and targets for group 3 subtype medulloblastoma.
Li M; Han Y; Wang C; Kang W; Jiang W; Zhang L; Tang Y
J Exp Clin Cancer Res; 2022 Oct; 41(1):311. PubMed ID: 36273157
[TBL] [Abstract][Full Text] [Related]
3. Subgroup-Enriched Pathways and Kinase Signatures in Medulloblastoma Patient-Derived Xenografts.
Leskoske KL; Garcia-Mansfield K; Sharma R; Krishnan A; Rusert JM; Mesirov JP; Wechsler-Reya RJ; Pirrotte P
J Proteome Res; 2022 Sep; 21(9):2124-2136. PubMed ID: 35977718
[TBL] [Abstract][Full Text] [Related]
4. Clinical Prognostic Implications of Wnt Hub Genes Expression in Medulloblastoma.
Martins-da-Silva A; Baroni M; Salomão KB; das Chagas PF; Bonfim-Silva R; Geron L; Cruzeiro GAV; da Silva WA; Corrêa CAP; Carlotti CG; de Paula Queiroz RG; Marie SKN; Brandalise SR; Yunes JA; Scrideli CA; Valera ET; Tone LG
Cell Mol Neurobiol; 2023 Mar; 43(2):813-826. PubMed ID: 35366170
[TBL] [Abstract][Full Text] [Related]
5. Molecular subgroups of adult medulloblastoma: a long-term single-institution study.
Zhao F; Ohgaki H; Xu L; Giangaspero F; Li C; Li P; Yang Z; Wang B; Wang X; Wang Z; Ai L; Zhang J; Luo L; Liu P
Neuro Oncol; 2016 Jul; 18(7):982-90. PubMed ID: 27106407
[TBL] [Abstract][Full Text] [Related]
6. Primary microcephaly gene CENPE is a novel biomarker and potential therapeutic target for non-WNT/non-SHH medulloblastoma.
Fang H; Zhang Y; Lin C; Sun Z; Wen W; Sheng H; Lin J
Front Immunol; 2023; 14():1227143. PubMed ID: 37593739
[TBL] [Abstract][Full Text] [Related]
7. Effective inhibition of MYC-amplified group 3 medulloblastoma by FACT-targeted curaxin drug CBL0137.
Wang J; Sui Y; Li Q; Zhao Y; Dong X; Yang J; Liang Z; Han Y; Tang Y; Ma J
Cell Death Dis; 2020 Dec; 11(12):1029. PubMed ID: 33268769
[TBL] [Abstract][Full Text] [Related]
8. Subgroup-specific prognostic signaling and metabolic pathways in pediatric medulloblastoma.
Park AK; Lee JY; Cheong H; Ramaswamy V; Park SH; Kool M; Phi JH; Choi SA; Cavalli F; Taylor MD; Kim SK
BMC Cancer; 2019 Jun; 19(1):571. PubMed ID: 31185958
[TBL] [Abstract][Full Text] [Related]
9. Mir-449a, a potential diagnostic biomarker for WNT group of medulloblastoma.
Li Y; Jiang T; Shao L; Liu Y; Zheng C; Zhong Y; Zhang J; Chang Q
J Neurooncol; 2016 Sep; 129(3):423-431. PubMed ID: 27406588
[TBL] [Abstract][Full Text] [Related]
10. A Novel Method for Rapid Molecular Subgrouping of Medulloblastoma.
Gómez S; Garrido-Garcia A; Garcia-Gerique L; Lemos I; Suñol M; de Torres C; Kulis M; Pérez-Jaume S; Carcaboso ÁM; Luu B; Kieran MW; Jabado N; Kozlenkov A; Dracheva S; Ramaswamy V; Hovestadt V; Johann P; Jones DTW; Pfister SM; Morales La Madrid A; Cruz O; Taylor MD; Martin-Subero JI; Mora J; Lavarino C
Clin Cancer Res; 2018 Mar; 24(6):1355-1363. PubMed ID: 29351917
[No Abstract] [Full Text] [Related]
11. Proteomic profiling of medulloblastoma reveals novel proteins differentially expressed within each molecular subgroup.
Narayan V; Jaiswal J; Sugur H; Sd S; Rao S; Chatterjee A; Gowda H; A A; Somanna S; Santosh V
Clin Neurol Neurosurg; 2020 Sep; 196():106028. PubMed ID: 32580068
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA profiling of pediatric Medulloblastoma.
Kesherwani V; Shukla M; Coulter DW; Sharp JG; Joshi SS; Chaturvedi NK
BMC Med Genomics; 2020 Jun; 13(1):87. PubMed ID: 32591022
[TBL] [Abstract][Full Text] [Related]
13. Enrichment of Tumor-Infiltrating B Cells in Group 4 Medulloblastoma in Children.
Wu KS; Jian TY; Sung SY; Hsieh CL; Huang MH; Fang CL; Wong TT; Lin YL
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563678
[TBL] [Abstract][Full Text] [Related]
14. FoxG1 interacts with Bmi1 to regulate self-renewal and tumorigenicity of medulloblastoma stem cells.
Manoranjan B; Wang X; Hallett RM; Venugopal C; Mack SC; McFarlane N; Nolte SM; Scheinemann K; Gunnarsson T; Hassell JA; Taylor MD; Lee C; Triscott J; Foster CM; Dunham C; Hawkins C; Dunn SE; Singh SK
Stem Cells; 2013 Jul; 31(7):1266-77. PubMed ID: 23592496
[TBL] [Abstract][Full Text] [Related]
15. A preliminary study on the mechanism of VASH2 in childhood medulloblastoma.
Liu W; Fu Y; Wang M; Zhao J; Chen J; Wang Y; Qin H
Sci Rep; 2023 Oct; 13(1):17153. PubMed ID: 37821528
[TBL] [Abstract][Full Text] [Related]
16. Molecular Stratification of Medulloblastoma: Clinical Outcomes and Therapeutic Interventions.
Sursal T; Ronecker JS; Dicpinigaitis AJ; Mohan AL; Tobias ME; Gandhi CD; Jhanwar-Uniyal M
Anticancer Res; 2022 May; 42(5):2225-2239. PubMed ID: 35489737
[TBL] [Abstract][Full Text] [Related]
17. Molecular Classification of Medulloblastoma.
Kijima N; Kanemura Y
Neurol Med Chir (Tokyo); 2016 Nov; 56(11):687-697. PubMed ID: 27238212
[TBL] [Abstract][Full Text] [Related]
18. Histologic Correlates of Molecular Group 4 Pediatric Medulloblastoma: A Retrospective Canadian Review.
Triscott J; Yip S; Johnston D; Michaud J; Rassekh SR; Hukin J; Dunn S; Dunham C
Pediatr Dev Pathol; 2021; 24(4):309-317. PubMed ID: 33749384
[TBL] [Abstract][Full Text] [Related]
19. Coagulation and angiogenic gene expression profiles are defined by molecular subgroups of medulloblastoma: evidence for growth factor-thrombin cross-talk.
D'Asti E; Kool M; Pfister SM; Rak J
J Thromb Haemost; 2014 Nov; 12(11):1838-49. PubMed ID: 25163932
[TBL] [Abstract][Full Text] [Related]
20. Mutation and expression analysis in medulloblastoma yields prognostic variants and a putative mechanism of disease for i17q tumors.
Bien-Willner GA; Mitra RD
Acta Neuropathol Commun; 2014 Jul; 2():74. PubMed ID: 25030029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
